Publication: Off-label use of ketamine for treatment-resistant depression in clinical practice: European perspective.
No Thumbnail Available
Identifiers
Date
2019-04-29
Authors
López-Díaz, Álvaro
Murillo-Izquierdo, Manuel
Moreno-Mellado, Elisa
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Export
Abstract
Ketamine therapy for treatment-resistant depression in European national health systems may only be considered after attempting all evidence-based antidepressant strategies outlined in clinical guidelines. This paper seeks to explain the ethical, regulatory and procedural framework for the off-label use of ketamine for treatment-resistant depression within a public healthcare system.Declaration of interestNone.
Description
MeSH Terms
Antidepressive Agents
Depressive Disorder, Treatment-Resistant
Europe
Humans
Ketamine
Off-Label Use
Practice Guidelines as Topic
Safety
Depressive Disorder, Treatment-Resistant
Europe
Humans
Ketamine
Off-Label Use
Practice Guidelines as Topic
Safety
DeCS Terms
CIE Terms
Keywords
Treatment-resistant depression, antidepressants, ketamine